Replies to post #215380 on Bioelectronics Corp (BIEL)

[ddls]

According to trading BioElectronics is a hasbeen company.

[Rheeper]

Just did the math. Even if BIEL miraculously ships 1.5m devices this year I estimate there is a $9-$10million rounding error.

50% dilution (FEB 2017 FDA clearance to FEB 2020 FDA clearance) with another 10%+ dilution later this year is hardly “petty cash”. The sell-on-news reaction to the full-body FDA clearance should be worrisome because this is a harbinger of things to come if/when news of deals hit the tape.

Here is a more realistic model to predict BIEL’s share price outlook. 1) ongoing dilution + 2) pent-up selling pressure from existing minority shareholders = party over.